Mylan launches new ADHD treatment in US

US-based pharmaceuticals company Mylan has launched the Methylphenidate Hydrochloride Extended-Release Tablets USP in the country for the treatment of patients affected with attention deficit hyperactivity disorder (ADHD).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news